Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic MelanomaAilin Lepletier, Mark J. Smyth, Xian-Yang Li et al.|Clinical Cancer Research|2020Cited by 113
Resistance to immunotherapy is associated with high parenchymal PD1+CD8+/CD8+ T cells (PD1tR) driven by tumour CD155A. Lepletier de Oliveira, Mark J. Smyth, Jason Madore et al.|Annals of Oncology|2019Cited by 1